[
  {
    "date": "2023-12-30",
    "symbol": "ICCM",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 10533000,
    "shortterminvestments": 529000,
    "accountsreceivablenetcurrent": 103000,
    "inventorynet": 2275000,
    "prepaidexpenseandotherassetscurrent": 744000,
    "assetscurrent": 14184000,
    "operatingleaserightofuseasset": 679000,
    "propertyplantandequipmentnet": 1513000,
    "prepaidexpenseandotherassetsnoncurrent": 34000,
    "assetsnoncurrent": 2226000,
    "assets": 16410000,
    "accountspayablecurrent": 502000,
    "operatingleaseliabilitycurrent": 223000,
    "otherliabilitiescurrent": 3146000,
    "liabilitiescurrent": 3871000,
    "operatingleaseliabilitynoncurrent": 376000,
    "liabilitiesnoncurrent": 376000,
    "additionalpaidincapital": 102224000,
    "retainedearningsaccumulateddeficit": -90061000,
    "stockholdersequity": 12163000,
    "liabilitiesandstockholdersequity": 16410000,
    "commonstocksharesauthorized": 2500000000,
    "commonstocksharesissued": 45729684,
    "commonstocksharesoutstanding": 45729684,
    "revenuefromcontractwithcustomerincludingassessedtax": 3229000,
    "costofrevenue": 1929000,
    "grossprofit": 1300000,
    "researchanddevelopmentexpense": 8273000,
    "sellingandmarketingexpense": 4437000,
    "generalandadministrativeexpense": 4166000,
    "operatingincomeloss": -15576000,
    "nonoperatingincomeexpense": 924000,
    "netincomeloss": -14652000,
    "earningspersharebasic": 0.32,
    "weightedaveragenumberofsharesoutstandingbasic": 45638030,
    "earningspersharediluted": 0.32,
    "weightedaveragenumberofdilutedsharesoutstanding": 45638030,
    "sharesoutstanding": 45729684,
    "stockissuedduringperiodvalueemployeebenefitplan": 28000,
    "stockissuedduringperiodvaluestockoptionsexercised": 83000,
    "stockissuedduringperiodsharesstockoptionsexercised": 106250,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationstockoptionsrequisiteserviceperiodrecognition": 1282000,
    "depreciation": 323000,
    "sharebasedcompensation": 1310000,
    "exchangeratechangesincashandcashequivalentsanddeposit": 25000,
    "increasedecreaseinaccountsreceivable": 25000,
    "increasedecreaseininventories": -582000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -496000,
    "increasedecreaseinotheroperatingassets": -182000,
    "increasedecreaseinaccountspayabletrade": -212000,
    "increasedecreaseinoperatingleaseliability": -191000,
    "increasedecreaseinothercurrentliabilities": -309000,
    "netcashprovidedbyusedinoperatingactivities": -12521000,
    "investmentofdeposits": -529000,
    "realizationofinvestmentinrestricteddeposits": -296000,
    "paymentstoacquirepropertyplantandequipment": 480000,
    "netcashprovidedbyusedininvestingactivities": -713000,
    "proceedsfromstockoptionsexercised": 83000,
    "netcashprovidedbyusedinfinancingactivities": 83000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -13151000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 10533000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 25000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 193000,
    "generalandadministrativeexpensestextblock": "NOTE 14 - GENERAL AND ADMINISTRATIVEEXPENSES  Composition:             Year ended December 31,      Year ended December 31,      Year ended December 31,             2023      2022      2021                                   Payroll and related benefits (including share-based compensation)      1,886       2,262       1,403       Professional services      1,966       3,369       2,440       Others      284       226       282              4,166       5,857       4,125",
    "severancepaypolicytextblock": "M.Severancepay:",
    "scheduleofannualdepreciationratestabletextblock": "Propertyand equipment are stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimateduseful lives of the related assets. The annual depreciation rates are as follows:",
    "scheduleofcostofrevenuestabletextblock": "Composition:",
    "scheduleofsalesandmarketingexpensestabletextblock": "Composition:",
    "generalandadministrativeexpensestabletextblock": "Composition:",
    "annualdepreciationrate": 0.15,
    "leaseholdimprovements": "Over the shorter of the related lease period or the useful lives of the asset",
    "inventoryrawmaterialsandsupplies": 1391000,
    "inventoryworkinprocess": 316000,
    "inventoryfinishedgoods": 568000,
    "prepaidtaxes": 114,
    "prepaidinsurance": 368,
    "prepaidexpensecurrentandnoncurrent": 144,
    "advancestopayables": 107,
    "otherprepaidexpensecurrent": 11,
    "operatingleasepayments": 246000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 276000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 257000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 145000,
    "lesseeoperatingleaseliabilitypaymentsdue": 678000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 79000,
    "operatingleaseliability": 599000,
    "propertyplantandequipmentgross": 1965000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 664000,
    "deferredrevenuecurrent": 187000,
    "accruedroyaltiescurrent": 47000,
    "accruedemployeebenefitscurrent": 1362000,
    "accruedvacationcurrent": 630000,
    "otheraccruedliabilitiescurrent": 920000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 1.22,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.194,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0386,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y21D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 3718621,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 2.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y4M28D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1157940,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 1.29,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 89194,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 2.48,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 319810,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 2.42,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 2.87,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1590516,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P5Y11M15D",
    "costdirectlabor": 551000,
    "costdirectmaterial": 905000,
    "directoperatingcosts": 42000,
    "costofroyalties": 96000,
    "costdepreciationamortizationanddepletion": 161000,
    "othercostofoperatingrevenue": 174000,
    "researchanddevelopmentpayrollandrelatedbenefitsincludingsharebasedcompensation": 5395000,
    "rawmaterialssubcontractedworkandconsulting": 1593000,
    "clinicaltrials": 436000,
    "otherresearchanddevelopmentexpense": 849000,
    "employeebenefitsandsharebasedcompensation": 2239000,
    "professionalfees": 987000,
    "travelandentertainmentexpense": 354000,
    "marketingandadvertisingexpense": 92000,
    "salescommissionsandfees": 49000,
    "conferences": 323000,
    "othersellingandmarketingexpense": 393000,
    "laborandrelatedexpense": 1886000,
    "professionalandcontractservicesexpense": 1966000,
    "othergeneralandadministrativeexpense": 284000,
    "deferredtaxassetsoperatinglosscarryforwards": 18608000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsother": 145000,
    "deferredtaxassetsgross": 18753000,
    "deferredtaxassetsvaluationallowance": 18753000,
    "currentstateandlocaltaxexpensebenefit": 14652000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.23,
    "incometaxreconciliationforeignincometaxratedifferential": 3370000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": -3370000,
    "concentrationriskpercentage1": 0.14,
    "deferredrevenue": 187000,
    "severancepercentageofmonthlysalary": 0.0833,
    "taxbenefitlargestamount": 0.5,
    "lesseeoperatingleasedescription": "the Company expandedits leases from 494 square meters to approximately 581 square meters at its location in Caesarea, Israel, and extended its operating leaseagreement for another 12 months until July 14, 2022, with an option to extend until July 14, 2025.",
    "bankguarantee": 20000,
    "operatingleaserightofuseassetamortizationexpense": 679000,
    "operatingleaseexpense": 599000,
    "revenueratepercentage": 0.035,
    "annualturnover": 70000000,
    "royaltiesattherate": 0.03,
    "liabilityforroyalties": 47000,
    "proceedsfromgrantors": 2630000,
    "royaltyexpense": 2084000,
    "deposits": 71000,
    "losscontingencydamagessoughtvalue": 30000000,
    "stockholdersequityreversestocksplit": "Accordingly, all option numbers, share numbers, share prices, exercise prices and lossesper share were adjusted within these consolidated financial statements, on a retroactive basis, to reflect this 8-for-1 reverse stocksplit.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 244926,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 92000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 1.12,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 1229000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P3Y7M6D",
    "revenueremainingperformanceobligationexpectedtimingofsatisfactionexplanation": "On June 12 2022, the Chinese Subsidiary signed an exclusive sale anddistribution agreement for the Systems and disposables with Shanghai Medtronic Zhikang Medical Devices Co. Ltd. (“Shanghai MedtronicZhikang”) and Turing for an initial term of 36 months, with a minimum purchase target of $3.5 million within this term.",
    "revenueremainingperformanceobligation": 4250000,
    "revenueperformanceobligationdescriptionofpaymentterms": "In addition,milestones have been set, for which, if met, the Company will receive the following amounts (that were identified by the Company asvariable consideration):(1)$250 will be paid to the Company upon the submission of an application for regulatory approval for theproducts in Japan;(2)$250 will be paid to the Company upon the receipt of regulatory approval in Japan; and(3)$500 will be paid to the Company upon the receipt of approval for medical reimbursement for the procedurein Japan",
    "increasedecreaseincontractwithcustomerliability": 4000000,
    "contractwithcustomerliabilityrevenuerecognized": 4250000,
    "incometaxesdescription": "The Chinese subsidiary is subjectto a progressive tax rate in China of 2.5% up to taxable income of one million RMB, 5% on taxable income between one million RMB to threemillion RMB and 25% on taxable income higher than three million RMB, for the year ended December 31, 2023 and 2022.",
    "operatinglosscarryforwards": 80906000,
    "concentrationriskthresholdpercentage": 0.1,
    "entityregistrantname": "ICECURE MEDICAL LTD.",
    "tradingsymbol": "ICCM",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "--12-31",
    "entitycommonstocksharesoutstanding": 45729684,
    "amendmentflag": "false",
    "entitycentralindexkey": 1584371,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "false",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-40753",
    "entityincorporationstatecountrycode": "L3",
    "entityaddressaddressline1": "7 Ha’Eshel St",
    "entityaddressaddressline2": "PO Box 3163",
    "entityaddresscityortown": "Caesarea",
    "entityaddresspostalzipcode": 3079504,
    "entityaddresscountry": "IL",
    "contactpersonnelname": "Eyal Shamir",
    "cityareacode": 972,
    "localphonenumber": 4.6230333,
    "security12btitle": "Ordinary Shares, no par value",
    "securityexchangename": "NASDAQ",
    "entityinteractivedatacurrent": "Yes",
    "documentfinstmterrorcorrectionflag": "false",
    "documentaccountingstandard": "U.S. GAAP",
    "auditorfirmid": 1197,
    "auditorname": "Brightman Almagor Zohar & Co.",
    "auditorlocation": "Tel Aviv, Israel"
  },
  {
    "date": "2022-12-31",
    "symbol": "ICCM",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 23659000,
    "depositsassetscurrent": 296000,
    "accountsreceivablenetcurrent": 78000,
    "inventorynet": 2857000,
    "otherprepaidexpensecurrent": 164000,
    "assetscurrent": 28130000,
    "financeleaserightofuseasset": 668000,
    "propertyplantandequipmentnet": 1356000,
    "prepaidexpensesandotherlongtermassets": 34000,
    "assetsnoncurrent": 2058000,
    "assets": 30188000,
    "accountspayablecurrent": 714000,
    "operatingleaseliabilitycurrent": 167000,
    "otherliabilitiescurrent": 3455000,
    "liabilitiescurrent": 4336000,
    "operatingleaseliabilitynoncurrent": 430000,
    "liabilitiesnoncurrent": 430000,
    "additionalpaidincapital": 100831000,
    "retainedearningsaccumulateddeficit": -75409000,
    "stockholdersequity": -75409000,
    "liabilitiesandstockholdersequity": 30188000,
    "commonstocksharesauthorized": 2500000000,
    "commonstocksharesissued": 45623434,
    "commonstocksharesoutstanding": 45623434,
    "revenues": 3085000,
    "costofrevenue": 1640000,
    "grossprofit": 1445000,
    "researchanddevelopmentexpense": 9123000,
    "sellingexpense": 3204000,
    "generalandadministrativeexpense": 5857000,
    "operatingincomeloss": -16739000,
    "nonoperatingincomeexpense": -239000,
    "comprehensiveincomenetoftaxincludingportionattributabletononcontrollinginterest": -16978000,
    "earningspersharebasic": 0.46,
    "weightedaveragenumberofsharesoutstandingbasic": 37016631,
    "earningspersharediluted": 0.46,
    "weightedaveragenumberofdilutedsharesoutstanding": 37016631,
    "sharesoutstanding": 45623434,
    "stockissuedduringperiodvalueother": 6000,
    "stockissuedduringperiodsharesother": 21000,
    "stockissuedduringperiodvaluenewissues": 13569000,
    "stockissuedduringperiodsharesnewissues": 8787880,
    "prefundedwarrantsexercised": 1000,
    "prefundedwarrantsexercisedinshares": -1034000,
    "stockissuedduringperiodvaluestockoptionsexercised": 1000,
    "optionsexercisedinshares": 219,
    "stockissuedduringperiodvaluesharebasedcompensation": 1865000,
    "profitloss": -16978000,
    "netincomeloss": -16978000,
    "depreciation": 248000,
    "sharebasedcompensation": 1865000,
    "exchangeratechangesincashandcashequivalentsandshorttimedeposits": 359000,
    "increasedecreaseinaccountsreceivable": -378000,
    "increaseininventory": 902000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -1050000,
    "increaseinrightofuseassets": -245000,
    "increasedecreaseinaccountspayabletrade": -167000,
    "increasedecreaseinoperatingleaseliability": -312000,
    "increasedecreaseinothercurrentliabilities": 540000,
    "increasedecreaseinothernoncurrentliabilities": -618000,
    "netcashprovidedbyusedinoperatingactivities": -14292000,
    "paymentstoacquirepropertyplantandequipment": 891000,
    "netcashprovidedbyusedininvestingactivities": -891000,
    "proceedsfromissuanceofcommonstock": 13569000,
    "issuanceofrestrictedordinaryshares": 6000,
    "proceedsfromissuanceofwarrants": 1000,
    "exerciseofoptionstoordinaryshares": 1000,
    "netcashprovidedbyusedinfinancingactivities": 13577000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -1606000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 23659000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": -356000,
    "generaltextblock": "NOTE 1 - GENERAL ",
    "costofrevenuestextblock": "NOTE 11 - COST OF REVENUES ",
    "salesandmarketingexpensestextblock": "NOTE 13\t- SALES AND MARKETING EXPENSES ",
    "generalandadministrativeexpensestextblock": "NOTE 14 - GENERAL AND ADMINISTRATIVEEXPENSES  ",
    "severancepaypolicytextblock": "M.Severance pay: ",
    "scheduleofannualdepreciationratestabletextblock": "            %                     Consoles and equipment      15 - 20       Computers and software      33       Office furniture and equipment      7 - 15       Leasehold improvements      Over the shorter of the related lease period or the useful lives of the asset    ",
    "scheduleofweightedaverageleasetermandweightedaveragediscountratetabletextblock": "      Operating leases weighted average remaining lease term (in years)      2.26       Operating leases weighted average discount rate      7.99%  ",
    "scheduleofrevenuesfromwarrantyandservicesarenotmaterialtabletextblock": "            Year endedDecember 31,      Year endedDecember 31,      Year ended                                                                                December 31,             2022      2021      2020                                   Consoles      1,002       1,560       1,817       Disposables      1,336       1,208       1,006       Exclusive distribution agreement      747       1,370       1,045              3,085       4,138       3,868    ",
    "scheduleofresearchanddevelopmentexpensestabletextblock": "            Year endedDecember 31,      Year endedDecember 31,      Year endedDecember 31,             2022      2021      2020                                   Payroll and related benefits (including share-based compensation)      5,969       3,748       2,273       Raw materials subcontracted work and consulting      1,742       1,440       1,058       Clinical trials      495       200       159       Others      917       489       319              9,123       5,877       3,809   ",
    "generalandadministrativeexpensestabletextblock": "            Year endedDecember 31,      Year endedDecember 31,      Year endedDecember 31,             2022      2021      2020                                   Payroll and related benefits (including share-based compensation)      2,262       1,403       965       Professional services      3,369       2,440       611       Others      226       282       138              5,857       4,125       1,714   ",
    "scheduleofsetsforthreportingpropertyandequipmentsegmenttabletextblock": "            As ofDecember 31,      As ofDecember 31,             2022      2021       Israel      929       622       United States      427       91              1,356       713    ",
    "annualdepreciationrate": 0.15,
    "leaseholdimprovements": "Over the shorter of the related lease period or the useful lives of the asset",
    "inventoryrawmaterialsandsupplies": 1566000,
    "inventoryworkinprocess": 356000,
    "inventoryfinishedgoods": 935000,
    "taxauthorities": 124000,
    "prepaidinsurance": 527000,
    "prepaidexpensecurrentandnoncurrent": 80000,
    "advancestopayables": 345000,
    "otherassetscurrent": 1240000,
    "operatingleasepayments": 242000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 214000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 196000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 182000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 105000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 697000,
    "receivablewithimputedinterestnetamount": 100000,
    "operatingleaseliability": 597000,
    "operatingleaseweightedaverageremainingleaseterm1": 2.26,
    "operatingleaseweightedaveragediscountratepercent": 0.0799,
    "propertyplantandequipmentgross": 2262000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 906000,
    "deferredrevenuecurrent": 646000,
    "paymentsforroyalties": 47000,
    "accruedemployeebenefitscurrent": 1580000,
    "accruedvacationcurrent": 554000,
    "otheremployeerelatedliabilitiescurrent": 628000,
    "employeerelatedliabilitiescurrent": 3455000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 3.61,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.9159999999999999,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.024300000000000002,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 3075935,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 2.55,
    "weightedaverageremainingcontractualtermsinyearsendingbalance": 7.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1806316,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 3.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 3380,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpiredinperiodweightedaverageexerciseprice": 3.43,
    "numberofshareoptionsforfeited": -63262,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 2.04,
    "stockissuedduringperiodsharesstockoptionsexercised": 219,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 1.64,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 1059573,
    "weightedaverageexercisepricepershareexercisableattheendofyear": 1.48,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 5.7,
    "costofrevenues1": 137000,
    "salesandmarketing": 208000,
    "otherresearchanddevelopmentexpense": 785000,
    "sellinggeneralandadministrativeexpense": 735000,
    "allocatedsharebasedcompensationexpense": 1865000,
    "consolesrevenues": 1002000,
    "disposablesreveues": 1336000,
    "exclusivedistributionagreementrevenues": 747000,
    "costofrevenuepayrollandrelatedbenefitsincludingsharebasedcompensation": 896000,
    "inventoryrawmaterials": 298000,
    "costofshipping": 48000,
    "costofroyalties": 93000,
    "depreciation1": 111000,
    "costofothers": 194000,
    "researchanddevelopmentpayrollandrelatedbenefitsincludingsharebasedcompensation": 5969000,
    "inventoryworkinprocessandrawmaterials": 1742000,
    "clinicaltrials": 495000,
    "othergeneralexpense": 917000,
    "researchanddevelopmentexpensesnet": 9123000,
    "employeebenefitsandsharebasedcompensation": 1599000,
    "professionalfees": 431000,
    "travelandentertainmentexpense": 274000,
    "marketingandadvertisingexpense": 74000,
    "salescommissionsandfees": 13000,
    "conferences": 301000,
    "otherexpenses": 512000,
    "sellingandmarketingexpense": 3204000,
    "payrollandrelatedbenefitsincludingsharebasedcompensation": 2262000,
    "professionalandcontractservicesexpense": 3369000,
    "othergeneralandadministrativeexpense": 226000,
    "totalcomposition": 5857000,
    "deferredtaxassetsoperatinglosscarryforwards": 17183000,
    "accountsnotesandloansreceivablenetcurrent": 127000,
    "deferredtaxassetsgross": 17310000,
    "deferredtaxassetsvaluationallowance": 17310000,
    "currentstateandlocaltaxexpensebenefit": 16952000,
    "currentforeigntaxexpensebenefit": 26000,
    "netincomelosses": 16978000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.23,
    "theoreticaltaxbenefit": 3905000,
    "lossesandotheritemsforwhichavaluationallowancewasprovidedorbenefitfromlosscarryforwards": -3905000,
    "revenuesegment": 3085000,
    "propertyandequipmentsegment": 1356000,
    "revenueremainingperformanceobligationpercentage": 0.2,
    "deferredrevenue": 646000,
    "deferredrevenuepresentsofcurrent": 646000,
    "derivativefixedinterestrate": 0.0833,
    "taxbenefitlargestamount": 0.5,
    "bankguarantee": 20,
    "operatingleaserightofuseasset": 668000,
    "leveragedleasesnetinvestmentinleveragedleasesdisclosureinvestmentinleveragedleasesnet": 597000,
    "costdepreciationamortizationanddepletion": 248000,
    "revenueratepercentage": 0.035,
    "annualturnover": 70000000,
    "royaltiesattherate": 0.03,
    "liabilityforroyalties": 47000,
    "accumulatedcapitalizedinterestcosts": 2575000,
    "prepaidroyalties": 2076000,
    "deposits": 296000,
    "plaintiff": 30000000,
    "claim": 9191000,
    "classaction": 163459000,
    "classdamages": 50079000,
    "plaintiffclaims": 234349000,
    "allegedly": 71798000,
    "secondtranche": 6000000,
    "limitedliabilitycompanyllcpreferredunitissued": 4594279,
    "outstandingandexercisableoptionsshares": 583281,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 316000,
    "fairvaluegrantedoptionspershare": 1.82,
    "unrecognizedsharebasedcompensationcost": 1783000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": 3.2,
    "regulatedoperatingrevenueother": 1000000,
    "paymentsforadvancetoaffiliate": 3000000,
    "applicationforregulatoryapproval": 250000,
    "receiptofregulatoryapproval": 250000,
    "medicalreimbursement": 500000,
    "identifiedperformanceobligations": 4250000,
    "consolesanddisposables": 866000,
    "regulatoryapproval": 250000,
    "assistanceinobtainingtheregulatoryapproval": 3134000,
    "companyreceived": 4000000,
    "totalconsideration": 3727000,
    "effectiveincometaxratecontinuingoperations": 0.21,
    "incometaxesdescription": "The China subsidiary is subject toChina tax rate of 2.5% up to taxable income of one million RMB, 5% on taxable income between one million RMB to three million RMB and20% on taxable income higher than three million RMB, for the year ended December 31, 2022. ",
    "accumulatedtaxloss": 74710000,
    "deferredtaxassetsotherlosscarryforwards": 17310000,
    "totalrevenuepercentage": 0.1,
    "entityregistrantname": "ICECURE MEDICAL LTD.",
    "tradingsymbol": "ICCM",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "December 31",
    "entitycommonstocksharesoutstanding": 45623434,
    "amendmentflag": "false",
    "entitycentralindexkey": 1584371,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "true",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-40753",
    "entityincorporationstatecountrycode": "Israel",
    "entityaddressaddressline1": "7 Ha’Eshel St",
    "entityaddressaddressline2": "PO Box 3163",
    "entityaddresscityortown": "Caesarea",
    "entityaddresspostalzipcode": 3079504,
    "entityaddresscountry": "Israel",
    "contactpersonnelname": "Eyal Shamir",
    "cityareacode": 972,
    "localphonenumber": 4.6230333,
    "security12btitle": "Ordinary Shares, no par value",
    "securityexchangename": "Nasdaq",
    "entityinteractivedatacurrent": "Yes",
    "documentaccountingstandard": "U.S. GAAP",
    "auditorfirmid": 1197,
    "auditorname": "Brightman Almagor Zohar & Co.",
    "auditorlocation": "Tel Aviv, Israel"
  },
  {
    "date": "2021-12-31",
    "symbol": "ICCM",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 25621000,
    "accountsreceivablenetcurrent": 456000,
    "inventorynet": 1955000,
    "otherprepaidexpensecurrent": 187000,
    "assetscurrent": 30322000,
    "financeleaserightofuseasset": 913000,
    "propertyplantandequipmentnet": 713000,
    "prepaidexpensesandotherlongtermassets": 333000,
    "assetsnoncurrent": 1959000,
    "assets": 32281000,
    "accountspayablecurrent": 881000,
    "operatingleaseliabilitycurrent": 224000,
    "otherliabilitiescurrent": 2915000,
    "liabilitiescurrent": 4020000,
    "operatingleaseliabilitynoncurrent": 685000,
    "otherlongtermdebtnoncurrent": 618000,
    "liabilitiesnoncurrent": 1303000,
    "additionalpaidincapital": 85389000,
    "retainedearningsaccumulateddeficit": -58431000,
    "stockholdersequity": -58431000,
    "liabilitiesandstockholdersequity": 32281000,
    "commonstocksharesauthorized": 2500000000,
    "commonstocksharesissued": 35780335,
    "commonstocksharesoutstanding": 35780335,
    "excessstocksharesissued": 1034000,
    "excessstocksharesoutstanding": 1034000,
    "revenues": 4138000,
    "costofrevenue": 1943000,
    "grossprofit": 2195000,
    "researchanddevelopmentexpense": 5877000,
    "sellingexpense": 1917000,
    "generalandadministrativeexpense": 4125000,
    "operatingincomeloss": 9724000,
    "nonoperatingincomeexpense": 171000,
    "comprehensiveincomenetoftaxincludingportionattributabletononcontrollinginterest": 9895000,
    "earningspersharebasic": 0.35,
    "weightedaveragenumberofsharesoutstandingbasic": 28548676,
    "sharesoutstanding": 1034000,
    "stockissuedduringperiodvalueother": 14586000,
    "stockissuedduringperiodsharesother": 11485697,
    "stockissuedduringperiodvaluenewissues": 12400000,
    "stockissuedduringperiodsharesnewissues": 3892152,
    "issuanceofprefundedwarrant": 3566000,
    "issuanceofprefundedwarrantinshares": 1034000,
    "stockissuedduringperiodvaluestockoptionsexercised": 337000,
    "optionsexercisedinshares": 189700,
    "stockissuedduringperiodvaluesharebasedcompensation": 316000,
    "stockgrantedduringperiodvaluesharebasedcompensationforfeited": -41000,
    "cancelationoftreasurysharesinshares": 5434,
    "profitloss": -9895000,
    "netincomeloss": -9895000,
    "depreciation": 127000,
    "sharebasedcompensation": 316000,
    "exchangeratechangesincashandcashequivalentsandshorttimedeposits": 5000,
    "increasedecreaseinaccountsreceivable": 362000,
    "increaseininventory": 891000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 2030000,
    "increaseinrightofuseassets": 607000,
    "increasedecreaseinaccountspayabletrade": 236000,
    "increasedecreaseinoperatingleaseliability": 577000,
    "increasedecreaseinothercurrentliabilities": 60000,
    "increasedecreaseinothernoncurrentliabilities": -141000,
    "netcashprovidedbyusedinoperatingactivities": -12605000,
    "investmentofdeposits": 4621000,
    "paymentstoacquirerestrictedcertificatesofdeposit": 296000,
    "paymentstoacquirepropertyplantandequipment": 533000,
    "netcashprovidedbyusedininvestingactivities": 3792000,
    "proceedsfromissuanceofcommonstock": 14586000,
    "issuanceofordinarysharesnetofissuanceexpenses": 15966000,
    "exerciseofoptionstoordinaryshares": 337000,
    "netcashprovidedbyusedinfinancingactivities": 30889000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 22076000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 25621000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": 43000,
    "generaltextblock": "      NOTE 1 -    GENERAL   ",
    "costofrevenuestextblock": "NOTE 12 -COST OF                                            REVENUES ",
    "salesandmarketingexpensestextblock": "NOTE 14 -SALES AND                                            MARKETING EXPENSES ",
    "generalandadministrativeexpensestextblock": "NOTE 15 -GENERAL                                            AND ADMINISTRATIVE EXPENSES ",
    "severancepaypolicytextblock": "M.Severance pay: ",
    "treasurysharespolicytextblock": "N.Treasury shares: ",
    "scheduleofannualdepreciationratestabletextblock": "            %                     Consoles and equipment     15 - 20       Computers and software     33       Office furniture and equipment     7 - 15       Leasehold improvements     Over the shorter of the related lease period or the useful lives of the asset    ",
    "scheduleofweightedaverageleasetermandweightedaveragediscountratetabletextblock": "      Operating leases weighted average remaining lease term (in years)      2.36       Operating leases weighted average discount rate      4.59%  ",
    "scheduleofcompositiontabletextblock": "            Year ended    December 31,      Year ended    December 31,             2021      2020                            Consoles      1,560       1,817       Disposables      1,208       1,006       Exclusive distribution agreement      1,370       1,045              4,138       3,868    ",
    "scheduleofcostofrevenuestabletextblock": "            Year ended     December 31,      Year ended    December 31,             2021      2020                            Payroll and related benefits (including share-based    compensation)      796       655       Raw materials subcontractors and auxiliary materials      828       461       Shipping      50       39       Royalties to the IIA      123       116       Others      146       153              1,943       1,424   ",
    "scheduleofresearchanddevelopmentexpensestabletextblock": "            Year ended     December 31,      Year ended    December 31,             2021      2020                            Payroll and related benefits (including share-based compensation)      3,748       2,273       Raw materials subcontracted work and consulting      1,440       1,058       Others      689       478              5,877       3,809   ",
    "scheduleofsalesandmarketingexpensestabletextblock": "            Year ended    December 31,      Year ended    December 31,             2021      2020                            Payroll and related benefits (including share-based compensation)      1,036       576       Consulting and professional services      215       157       Travel      126       29       Advertising and promotion expenses      60       36       Sales commissions      60       57       Others      420       208              1,917       1,063   ",
    "generalandadministrativeexpensestabletextblock": "            Year ended     December 31,      Year ended     December 31,             2021      2020                            Payroll and related benefits (including share-based compensation)      1,403       965       Professional services      2,440       611       Others      282       138              4,125       1,714   ",
    "scheduleofsetsforthreportingpropertyandequipmentsegmenttabletextblock": "            As of     December 31,      As of     December 31,             2021      2020       Israel      622       305       United States      91       2              713       307    ",
    "annualdepreciationrate": 0.15,
    "leaseholdimprovements": "Over the shorter of the related lease period or the useful lives of the asset",
    "inventoryrawmaterialsandsupplies": 704000,
    "inventoryworkinprocess": 457000,
    "inventoryfinishedgoods": 794000,
    "taxauthorities": 128000,
    "prepaidinsurance": 1700000,
    "prepaidexpensecurrentandnoncurrent": 275000,
    "otherassetscurrent": 2290000,
    "operatingleasepayments": 247000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 270000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 241000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 213000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 196000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 83000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 1003000,
    "receivablewithimputedinterestnetamount": 94000,
    "operatingleaseliability": 909000,
    "operatingleaseweightedaverageremainingleaseterm1": 2.36,
    "operatingleaseweightedaveragediscountratepercent": 0.045899999999999996,
    "propertyplantandequipmentgross": 1011000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 298000,
    "deferredrevenuecurrent": 884000,
    "paymentsforroyalties": 2135000,
    "accruedemployeebenefitscurrent": 991000,
    "accruedvacationcurrent": 410000,
    "otheremployeerelatedliabilitiescurrent": 568000,
    "employeerelatedliabilitiescurrent": 2915000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 8.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.961,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0102,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6.22,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 1336480,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 1.64,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 108929,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 2.02,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 13875,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpiredinperiodweightedaverageexerciseprice": 2.94,
    "numberofshareoptionsforfeited": -24635,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 1.85,
    "stockissuedduringperiodsharesstockoptionsexercised": 189700,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 2.06,
    "weightedaverageremainingcontractualtermsinyearsendingbalance": 7.03,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 858994,
    "weightedaverageexercisepricepershareexercisableattheendofyear": 1.55,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 6.36,
    "costofrevenues1": 15000,
    "salesandmarketing": 15000,
    "otherresearchanddevelopmentexpense": 109000,
    "sellinggeneralandadministrativeexpense": 177000,
    "allocatedsharebasedcompensationexpense": 316000,
    "consolesrevenues": 1560000,
    "disposablesreveues": 1208000,
    "exclusivedistributionagreementrevenues": 1370000,
    "costofrevenuepayrollandrelatedbenefitsincludingsharebasedcompensation": 796000,
    "inventoryrawmaterials": 828000,
    "costofshipping": 50000,
    "costofroyalties": 123000,
    "costofothers": 146000,
    "researchanddevelopmentpayrollandrelatedbenefitsincludingsharebasedcompensation": 3748000,
    "inventoryworkinprocessandrawmaterials": 1440000,
    "othergeneralexpense": 689000,
    "researchanddevelopmentexpensesnet": 5877000,
    "employeebenefitsandsharebasedcompensation": 1036000,
    "professionalfees": 215000,
    "travelandentertainmentexpense": 126000,
    "marketingandadvertisingexpense": 60000,
    "salescommissionsandfees": 60000,
    "otherexpenses": 420000,
    "sellingandmarketingexpense": 1917000,
    "payrollandrelatedbenefitsincludingsharebasedcompensation": 1403000,
    "professionalandcontractservicesexpense": 2440000,
    "othergeneralandadministrativeexpense": 282000,
    "totalcomposition": 4125000,
    "deferredtaxassetsoperatinglosscarryforwards": 14113000,
    "accountsnotesandloansreceivablenetcurrent": 94000,
    "deferredtaxassetsgross": 14207000,
    "deferredtaxassetsvaluationallowance": 14207000,
    "currentstateandlocaltaxexpensebenefit": 10081000,
    "currentforeigntaxexpensebenefit": -186000,
    "netincomelosses": 9895000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.23,
    "theoreticaltaxbenefit": 2276000,
    "lossesandotheritemsforwhichavaluationallowancewasprovidedorbenefitfromlosscarryforwards": -2161000,
    "otheraccruedliabilitiescurrent": 115000,
    "revenuesegment": 4138000,
    "propertyandequipmentsegment": 713000,
    "revenueremainingperformanceobligationpercentage": 0.11,
    "deferredrevenue": 1502000,
    "deferredrevenuepresentsofcurrent": 884000,
    "derivativefixedinterestrate": 0.0833,
    "taxbenefitlargestamount": 0.5,
    "warrantstopurchaseordinaryshares": 1034000,
    "operatingleaserightofuseasset": 913000,
    "leveragedleasesnetinvestmentinleveragedleasesdisclosureinvestmentinleveragedleasesnet": 909000,
    "costdepreciationamortizationanddepletion": 127000,
    "revenueratepercentage": 0.035,
    "annualturnover": 70000000,
    "royaltiesattherate": 0.03,
    "liabilityforroyalties": 62000,
    "accumulatedcapitalizedinterestcosts": 2527000,
    "deposits": 296000,
    "losscontingencynameofplaintiff": "The plaintiff estimated the amountof his individual claim at a sum of approximately NIS 30,000 (USD 9,191), the amount of the class action, insofar as it will be qualifiedas such, at a sum of approximately NIS 163,459 (USD 50,079) for the class damages that the plaintiff claims had their shares dilutedunlawfully, and at a sum of approximately NIS 234,349 (USD 71,798), for damage that was supposedly caused to the shareholders due toa sale at less than the full market price. ",
    "investmentdescription": "The second tranche of $6,000 was duefollowing the approval of the listing of the Company’s securities on Nasdaq (the “Second Closing Milestone” and suchdate, “the Second Closing Date”). In May 2021, the Company and the investors agreed to execute the second tranche prior tothe achievement of the Second Closing Milestone, and the second tranche of $6,000 was received on May 9, 2021. Accordingly, the Companyissued to the investors 4,594,279 shares. ",
    "stockholdersequityreversestocksplit": "Accordingly, all option numbers, share numbers, share prices, exercise prices and losses per share have been adjusted within these consolidated financial statements, on a retroactive basis, to reflect this 8-for-1 reverse stock split.",
    "outstandingandexercisableoptionsshares": 846105000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 1321000,
    "fairvaluegrantedoptionspershare": 6.89,
    "landpurchaseoptionsdescription": "the Company granted 100,000 options to purchase an aggregate of 100,000 ordinary shares to a member of the Company’s Board of directors, at an exercise price of $1.60 per share. The options will vest as follows:",
    "unrecognizedsharebasedcompensationcost": 217000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "four years",
    "regulatedoperatingrevenueother": 1000000,
    "paymentsforadvancetoaffiliate": 3000000,
    "applicationforregulatoryapproval": 250000,
    "receiptofregulatoryapproval": 250000,
    "medicalreimbursement": 500000,
    "identifiedperformanceobligations": 4250000,
    "consolesanddisposables": 866000,
    "regulatoryapproval": 250000,
    "assistanceinobtainingtheregulatoryapproval": 3134000,
    "companyreceived": 4000000,
    "totalconsideration": 3179000,
    "effectiveincometaxratecontinuingoperations": 0.21,
    "incometaxesdescription": "The China subsidiary  is subjectto China tax rate of 2.5% up to taxable income of one million RMB, 10% on taxable income between one million RMB to three million RMBand 25% on taxable income higher than three million RMB, for the year ended December 31, 2021. ",
    "accumulatedtaxloss": 61361000,
    "deferredtaxassetsotherlosscarryforwards": 14207000,
    "totalrevenuepercentage": 0.1,
    "entityregistrantname": "IceCure Medical Ltd.",
    "tradingsymbol": "ICCM",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "December 31",
    "entitycommonstocksharesoutstanding": 35780335,
    "amendmentflag": "false",
    "entitycentralindexkey": 1584371,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "true",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-40753",
    "entityincorporationstatecountrycode": "Israel",
    "entityaddressaddressline1": "7Ha’Eshel St.,",
    "entityaddressaddressline2": "PO Box 3163",
    "entityaddresscityortown": "Caesarea",
    "entityaddresspostalzipcode": 3079504,
    "entityaddresscountry": "Israel",
    "contactpersonnelname": "EyalShamir",
    "cityareacode": 972,
    "localphonenumber": 4.6230333,
    "security12btitle": "Ordinary Shares, no par value",
    "securityexchangename": "Nasdaq Global Market",
    "entityinteractivedatacurrent": "Yes",
    "documentaccountingstandard": "U.S. GAAP",
    "auditorfirmid": 1197,
    "auditorname": "Brightman Almagor Zohar & Co.",
    "auditorlocation": "Tel Aviv, Israel"
  }
]